AquaBounty Technologies, Inc. (AQB) es una empresa que cotiza en bolsa en el Consumo Defensivo sector, operando dentro de la Agricultural Farm Products industria. La empresa tiene su sede en Maynard, MA, United States. El CEO actual es David A. Frank.
AQB tiene fecha de IPO 2017-01-11, 4 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $4.34M.
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
